Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery..
Cabozantinib improves survival in patients with advanced kidney cancer Patients with advanced kidney cancer live for nearly twice as long without their disease progressing if they are treated with cabozantinib, a drug that inhibits the action of tyrosine kinases -- enzymes that function as an 'on' or 'off' switch in many cellular processes, including cancer.
Significant genetic differences between breast cancers that relapse and those that do not: Researchers have taken an important step towards understanding why some primary breast cancers return while others do not. The European Cancer Congress will hear that genetic factors driving the cancers that recur are different from those found in the cancers that do not. This discovery could enable doctors to identify patients at high risk of their cancer returning and to target the genes responsible for recurrence when the cancer is first diagnosed in order to prevent its return.
Attacking acute myeloid leukemia A team of researchers has demonstrated that a molecule isolated from sea sponges and later synthesized in the lab, can halt the growth of acute myeloid leukemia cells and could open the door to a new treatment for leukemia.
Multi-gene test enables some breast cancer patients to safely avoid chemotherapy The best evidence to date has been provided that suggests that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.